Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers

Inclusion Criteria:

• Body Mass Index (BMI) is >= 18.0 to <= 35.0 kg/m2.

• Supine pulse rate >= 50 bpm and <= 100 bpm obtained after a 5-minute rest atScreening.

• Supine systolic blood pressure (SBP) <= 160 mm Hg and >= 90 mm Hg and supinediastolic blood pressure (DBP) <= 90 mm Hg and obtained after a 5-minute rest atScreening.

Exclusion Criteria:

• Orthostatic (SBP decrease of >= 30 mmHg, DBP decrease of >= 20 mmHg, or pulseincrease of >= 30 bpm) as determined after standing for 5 minutes.

• Current or history of suicidal ideation as indicated by answering "Yes" answer toSuicidal Ideation Questions #4 or #5 on the Columbia-Suicide Severity Rating Scale (C-SSRS) at Screening in the past 3 months or any "Yes" answer to Suicidal BehaviorQuestions #1-5 in the past year. Non-suicidal self-injurious behavior is notexclusionary.

• History of suicide attempt(s) within 1 year prior to study drug administration asevidenced by answering "Yes" to any Suicidal Behavior Questions (a "Yes" toNon-Suicidal Self-Injurious Behavior is not exclusionary).

• Contraindications to MRIs (metal implants, paramagnetic objects contained within thebody, claustrophobia, etc.)

• Clinically significant findings as determined from screening brain MRI.

• History of previous radiation exposure for research purposes such that participationin this study will result in cumulative ionizing radiation exposure >10 mSv in thepast 12 months, in additional to normal background exposure.